Showing 6,661 - 6,680 results of 63,539 for search '(( 2 e decrease ) OR ( 50 ((((mean decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.28s Refine Results
  1. 6661
  2. 6662
  3. 6663
  4. 6664
  5. 6665

    NMR analyses of the HPV16 E6/E6APpep and HPV16 E6/pep11** interactions. by Katia Zanier (17371)

    Published 2014
    “…This decrease in signal intensity is concomitant with the appearance of a white precipitate of E6 in the NMR tube. …”
  6. 6666
  7. 6667

    Table_4_Clinical Features of 50 Patients With Primary Adrenal Lymphoma.DOCX by Yan Wang (15435)

    Published 2020
    “…<p>Background and Objective: Primary adrenal lymphoma is a rare, progressive, easily misdiagnosed adrenal tumor with a poor prognosis. …”
  8. 6668

    Table_1_Clinical Features of 50 Patients With Primary Adrenal Lymphoma.DOCX by Yan Wang (15435)

    Published 2020
    “…<p>Background and Objective: Primary adrenal lymphoma is a rare, progressive, easily misdiagnosed adrenal tumor with a poor prognosis. …”
  9. 6669

    Table_2_Clinical Features of 50 Patients With Primary Adrenal Lymphoma.DOCX by Yan Wang (15435)

    Published 2020
    “…<p>Background and Objective: Primary adrenal lymphoma is a rare, progressive, easily misdiagnosed adrenal tumor with a poor prognosis. …”
  10. 6670
  11. 6671
  12. 6672

    Image_2_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.JPEG by Yaqi Li (2936265)

    Published 2021
    “…Flow cytometry, WB and qPCR analyses were used to elucidate the role of QSOX2 in cell cycle regulation. Chromatin immunoprecipitation assay (ChIP) assay and Dual-Luciferase reporter assay were employed to investigate transcriptional regulation of QSOX2 by E2F Transcription Factor 1 (E2F1).…”
  13. 6673

    Table_2_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.DOCX by Yaqi Li (2936265)

    Published 2021
    “…Flow cytometry, WB and qPCR analyses were used to elucidate the role of QSOX2 in cell cycle regulation. Chromatin immunoprecipitation assay (ChIP) assay and Dual-Luciferase reporter assay were employed to investigate transcriptional regulation of QSOX2 by E2F Transcription Factor 1 (E2F1).…”
  14. 6674
  15. 6675

    Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: a pilot randomized clinical trial by Samuel Oliveira de Afonseca (12798419)

    Published 2022
    “…This study aimed to assess the effectiveness of vitamin E for prevention of oxaliplatin-induced peripheral neuropathy.DESIGN AND SETTINGProspective, phase II, randomized pilot study developed at a university hospital in the Greater ABC region.METHODSPatients were randomized five days before starting oxaliplatin treatment, to receive either vitamin E or placebo until the end of the chemotherapy regimen. …”
  16. 6676
  17. 6677
  18. 6678
  19. 6679
  20. 6680